rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

08 Nov,15:29
7291.00
-226.00 (-3.01%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

722 7,517.00 7,543.05 - 7,284.60 8,139.85 - 4,050.15 18,227.50
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

08 Nov,14:47
7372.10
-146.95 (-1.95%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

8,795 7519.05 7,560.00 - 7,326.20 8,139.00 - 4,510.00 65,429,435.05

News for AstraZeneca Pharma India Ltd.

Jubilant Ingrevia Joins WEF's Global Lighthouse Network
Jubilant Ingrevia's Gujarat facility joins the World Economic Forum's Global Lighthouse Network, showcasing its AI-driven manufacturing innovation. The network recognizes leading production...
Oct 08, 2024 14:48
Tamil Nadu...
Tamil Nadu Approves Rs 44,125 Cr Projects, Renewable Energy Policies
Tamil Nadu cabinet approves 15 investment proposals worth Rs 44,125 crore, including renewable energy policies and projects in electronics, food processing, and more. The state aims to generate...
Aug 13, 2024 17:55
AstraZeneca India Reports Q1 Net Loss of Rs 12 Crore
AstraZeneca Pharma India reported a net loss of Rs 12 crore for the first quarter ended June 30, 2024, compared to a profit of Rs 54 crore in the same period last year. Total income for the quarter...
Aug 08, 2024 18:49
Sanofi Gets CDSCO...
Sanofi Gets CDSCO Nod for Beyfortus in India - Prevention of RSV
Sanofi India receives marketing authorization for Beyfortus, a treatment for preventing Respiratory Syncytial Virus (RSV) in infants and children up to 24 months.
Aug 01, 2024 13:34
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

Signature Global...
Signature Global Profit Jumps in Q2 FY24 - Revenue Rises to Rs 777 cr
Signature Global reports a consolidated net profit of Rs 4.15 crore in Q2 FY24, a significant improvement from the previous year. Revenue surged to Rs 777.42 crore, driven by strong demand in the...
Nov 08, 2024 20:35
Govt Launches Rs...
Govt Launches Rs 500 Cr Medtech Scheme: Boosting India's Self-Reliance
The Indian government launches a Rs 500 crore scheme to strengthen the medical device industry, focusing on manufacturing, skill development, and industry promotion. This initiative aims to make...
Nov 08, 2024 20:32
Premji Invest...
Premji Invest Acquires 1.6% Stake in Wipro for Rs 4,757 Crore
Premji Invest, a private equity firm, has bought a 1.6% stake in Wipro for Rs 4,757 crore through an open market transaction. The deal was executed via a block deal on the NSE.
Nov 08, 2024 20:24
Tata Motors Urges...
Tata Motors Urges Govt Incentives for Electric Fleet Vehicles
Tata Motors's CFO calls for government incentives to boost electric vehicle adoption in the fleet segment, highlighting the impact of subsidy withdrawal on sales.
Nov 08, 2024 20:21
RBI Fines South...
RBI Fines South Indian Bank for Non-Compliance
The Reserve Bank of India (RBI) has imposed a penalty of Rs 59.20 lakh on South Indian Bank for non-compliance with directions on interest rates and customer service.
Nov 08, 2024 20:18

More News »

Top News

Signature Global...
Signature Global Profit Jumps in Q2 FY24 - Revenue Rises to Rs 777 cr
Signature Global reports a consolidated net profit of Rs 4.15 crore in Q2 FY24, a significant improvement from the previous year. Revenue surged to Rs 777.42 crore, driven by strong demand in the...
Nov 08, 2024 20:35
Govt Launches Rs...
Govt Launches Rs 500 Cr Medtech Scheme: Boosting India's Self-Reliance
The Indian government launches a Rs 500 crore scheme to strengthen the medical device industry, focusing on manufacturing, skill development, and industry promotion. This initiative aims to make...
Nov 08, 2024 20:32
NICDC & UP Govt Partner for Manufacturing Clusters in Agra & Prayagraj
NICDC and UP State Industrial Development Authority collaborate to develop integrated manufacturing clusters in Agra and Prayagraj, boosting industrial growth and employment opportunities.
Nov 08, 2024 20:28
Premji Invest...
Premji Invest Acquires 1.6% Stake in Wipro for Rs 4,757 Crore
Premji Invest, a private equity firm, has bought a 1.6% stake in Wipro for Rs 4,757 crore through an open market transaction. The deal was executed via a block deal on the NSE.
Nov 08, 2024 20:24
Tata Motors Urges...
Tata Motors Urges Govt Incentives for Electric Fleet Vehicles
Tata Motors's CFO calls for government incentives to boost electric vehicle adoption in the fleet segment, highlighting the impact of subsidy withdrawal on sales.
Nov 08, 2024 20:21

More Top News »

Report Card

PE Ratios
116.17
EPS (Rs.)
64.60
Sales (Rs. Cr)
387.52
Face Value (Rs.)
2
Net Profit Margin (%)
12.46
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
22.68

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,827.25
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,209.50
  • Compare
  • Zydus Lifesciences Ltd.
  • 995.00
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,969.85
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,083.00
  • Compare
  • Divi's Laboratories Ltd.
  • 5,939.70
  • Compare
  • Alkem Laboratories Ltd.
  • 5,852.85
  • Compare

Most Active

  • Change (Rs.)
  •  

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close